What did @lumenpeptidesnz actually say?
The creator framed CJC-1295 (no DAC) and ipamorelin as a synergistic duo, claiming the stack "doesn't add anything to your body" but instead tells it "what to do better." The pitch was direct: stronger muscles, unreal recovery, deeper sleep, better mood. The headline grab was "it feels like steroids, but it's not." They also positioned these peptides as exclusive to Lumen Peptides in New Zealand and encouraged direct contact for access.
To be clear about what was claimed: that this stack mimics youthful growth hormone pulsing, that CJC-1295 controls timing while ipamorelin controls volume of release, and that the two must be used together to work properly. These are specific mechanistic claims, not vague wellness promises. That makes them worth examining properly.
Does the science back this up?
Partially, yes, but with significant gaps between the mechanism and the marketing. CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), and ipamorelin is a selective growth hormone secretagogue. The idea that they work synergistically on different receptor pathways is supported in the literature, but the "feels like steroids" framing has no clinical backing.
A study by Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) confirmed CJC-1295 increases GH and IGF-1 levels in healthy adults. Ipamorelin's selectivity, meaning it raises GH without significantly spiking cortisol or prolactin, was demonstrated by Raun et al. (1998, European Journal of Endocrinology). So the receptor-level synergy story is real. What is not real is the claim that this translates to steroid-comparable muscle building in healthy adults. That extrapolation has no randomized controlled trial support in non-deficient populations. Most human data comes from GH-deficient patients or small, short-duration studies.
What did they get wrong (or right)?
Credit where it is due: the mechanistic split between CJC-1295 and ipamorelin is accurate. CJC-1295 acts on GHRH receptors to prime release timing, and ipamorelin acts on ghrelin receptors to amplify pulse amplitude. Saying "without me there's no timing, without him there's no control" is a simplified but defensible description of why these two are commonly stacked.
What is wrong, and plainly so, is the "feels like steroids" comparison. Anabolic steroids directly bind androgen receptors and drive protein synthesis at a pharmacological level that no GH secretagogue stack replicates. Framing this as equivalent in effect is misleading to anyone who takes it literally. It also contradicts the creator's own claim that this stack "doesn't add anything." Supraphysiological GH pulses, which is what you are chasing with this stack, do add something. They raise IGF-1 above baseline. That is not the same as simply restoring what you had at 25.
The "your biology working properly again" framing also glosses over real side effect potential: fluid retention, joint pain, increased fasting glucose, and, with prolonged use, potential desensitization of GH receptors. None of that was mentioned.
What should you actually know?
If you are considering this stack, the honest picture is this: there is legitimate science behind the mechanism, limited but real human data showing GH and IGF-1 elevation, and essentially no long-term safety data in healthy adults using these compounds for body composition goals. A review by Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted that while GH secretagogues show promise, the evidence base for their use in healthy, non-deficient individuals remains thin and largely extrapolated from animal or GH-deficient human studies.
In New Zealand, CJC-1295 and ipamorelin are not approved therapeutic products. Purchasing them through direct social media contact raises real questions about quality control, sterility, and dosing accuracy that the video does not address at all. The "easy to access here in NZ" framing treats regulatory status as a logistics problem rather than a safety signal. It is worth knowing the difference.